Devgen Receives EUR20 Million In Updated Deal With Monsanto
April 24 2009 - 1:42AM
Dow Jones News
Belgian biotechnology company Devgen NV (DEVG.BT) Friday said it
has recieved EUR20 million from Monsanto Co. (MON) in a revision of
their 2007 cooperation pact.
Monsanto now has broader rights to Devgen technology. In
exchange, Devgen receives EUR20 million in cash. Additional details
of the agreement were not disclosed.
Company Web site: http://www.devgen.com